GammaTile® Therapy is FDA-cleared as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms, including brain metastases, glioblastomas, and meningiomas.Continue reading→

The University of Arizona Health Sciences is one of five sites that will be tracking the burden, distribution and impact of post COVID-19 conditions.
Continue reading→

TUCSON, Ariz., Dec. 09, 2022 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced it will host its next HTG Therapeutics key opinion leader (KOL) webinar: “The Role of RNA Profiling in Drug Discovery and Analysis”, on Tuesday, December 13, 2022 at 11:00 am Eastern Standard Time.Continue reading→

-JSR Lifesciences invested $1.5M toward the preferred series A capital raise, October 2022.

-The dosing of the P1A Healthy Human Volunteer Study with ALT-100 mAb is nearing completion, with no reported SAEs to date. Study to conclude by Q2 2023.Continue reading→

Technology developed at TGen described in a new study.

PHOENIX, Ariz. — December 5, 2022 — With less than one microliter of blood plasma or serum, researchers can now use a customizable lab platform called PepSeq to observe how the tiny sample interacts with hundreds of thousands of protein building blocks.Continue reading→

TapRoot Interventions & Solutions, Inc (TapRoot) is partnering with psychiatric and behavioral health provider group Peace of Mind Consultants (POMC) in Arizona to provide Ella® to their patients and business partners. Ella is a digital careplan platform that provides  interventions to prevent, decrease, and de-escalate dementia-related and mental illness-related behavioral symptoms known to occur in  Long Term Care communities. POMC will use Ella to garner key insights from caregiver feedback in order to tailor patient-specific treatment plans and determine appropriate use of medications. The value of the partnership is a provider service model coupled with a caregiver platform to assess, evaluate, and provide outcome measures to improve overall resident care.Continue reading→

TUCSON, Ariz., Dec. 1, 2022 — Critical Path Institute (C-Path) and Ultragenyx Pharmaceutical, Inc., (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced a data sharing agreement to incorporate rare disease patient data into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).Continue reading→

ADP provides an experienced and practical approach for guiding life science clients through the R&D tax credit process. Their group of specialized professionals provide the peace of mind that comes with having a highly detailed study outlining qualified research activities and expenses.Continue reading→

For the first time, Research.com has published a list of the top 1,000 female scientists in the world.

Congratulations to Barbara Ainsworth, Carol Barnes, Carolyn Compton, Nancy Eisenberg, and Alexandra Navrotsky for this well earned recognition.Continue reading→